Forum · Medicine · Story discussion
Metastatic pancreatic cancer responds well to treatment with combination of daraxonrasib and chemotherapy
Daraxonrasib combined with chemotherapy caused substantial tumor shrinkage in patients with pancreatic cancer that had spread to other parts of the body, according to new results from a Phase I/II clinical trial.
2.3 hours ago — Medical Xpress · Read the original
Peer reviews (0)
Comments (0)
No comments yet. Start the discussion.
Loading sign-in…